CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on June 21, 2006
Clinical Journal of the American Society of Nephrology
© 2006 American Society of Nephrology
doi: 10.2215/CJN.00300106
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.00300106v1
1/4/655    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaffe, J. A.
Right arrow Articles by Kimmel, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaffe, J. A.
Right arrow Articles by Kimmel, P. L.


IN-DEPTH REVIEWS

Chronic Nephropathies of Cocaine and Heroin Abuse: A Critical Review

Jared A. Jaffe and Paul L. Kimmel 1

Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University Medical Center, Washington, DC


1 To whom correspondence should be addressed. E-mail: pkimmel{at}mfa.gwu.edu.


   Abstract

Renal disease in cocaine and heroin users is associated with the nephrotic syndrome, acute glomerulonephritis, amyloidosis, interstitial nephritis, and rhabdomyolysis. The pathophysiologic basis of cocaine-related renal injury involves renal hemodynamic changes, glomerular matrix synthesis and degradation, and oxidative stress and induction of renal atherogenesis. Heroin is the most commonly abused opiate in the United States. Previous studies identified a spectrum of renal diseases in heroin users. The predominant renal lesion in black heroin users is focal segmental glomerulosclerosis and in white heroin users is membranoproliferative glomerulonephritis. Although the prevalence of heroin use in the United States has increased, the incidence of "heroin nephropathy" has declined. Because reports of heroin nephropathy predated the surveillance of hepatitis C virus and HIV, the varied findings might be related to the spectrum of viral illnesses that are encountered in injection drug users. Socioeconomic conditions, cultural and behavioral practices, or differences in genetic susceptibilities may be more associated with the development of nephropathy in heroin users than the drug’s pharmacologic properties. Administration of cocaine in animal models results in nonspecific glomerular, interstitial, and tubular cell lesions, but there is no animal model of heroin-associated renal disease. The heterogeneity of responses that are associated with heroin is not consistent with a single or simple notion of nephropathogenesis. There are no well-designed, prospective, epidemiologic studies to assess the incidence and the prevalence of renal disease in populations of opiate users and to establish the validity of a syndrome such as heroin nephropathy. It is concluded although there is a paucity of evidence to support a heroin-associated nephropathy, the evidence from in vitro cellular and animal studies to support the existence of cocaine-induced renal changes is more convincing.




This article has been cited by other articles:


Home page
CJASNHome page
D. M. Fine, N. Garg, M. Haas, M. H. Rahman, G. M. Lucas, P. J. Scheel, and M. G. Atta
Cocaine Use and Hypertensive Renal Changes in HIV-Infected Individuals
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1125 - 1130.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. D. Cohen, L. Norris, K. Acquaviva, R. A. Peterson, and P. L. Kimmel
Screening, Diagnosis, and Treatment of Depression in Patients with End-Stage Renal Disease
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1332 - 1342.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Society of Nephrology.